title: Mast cell engraftment of the peripheral lung enhances airway hyperresponsiveness in a mouse asthma model.
abstract: Allergic asthma is a chronic inflammatory disease, characterized by airway hyperresponsiveness (AHR), inflammation, and tissue remodeling, in which mast cells play a central role. In the present study, we analyzed how mast cell numbers and localization influence the AHR in a chronic murine model of asthma. C57BL/6 (wild-type) and mast cell-deficient B6.Cg-Kit(W-sh) mice without (Wsh) and with (Wsh+MC) mast cell engraftment were sensitized to and subsequently challenged with ovalbumin for a 91-day period. In wild-type mice, pulmonary mast cells were localized in the submucosa of the central airways, whereas the more abundant mast cells in Wsh+MC mice were found mainly in the alveolar parenchyma. In Wsh+MC, ovalbumin challenge induced a relocation of mast cells from the perivascular space and central airways to the parenchyma. Allergen challenge caused a similar AHR in wild-type and Wsh mice in the resistance of the airways and the pulmonary tissue. In Wsh+MC mice the AHR was more pronounced. The elevated functional responses were partly related to the numbers and localization of connective tissue-type mast cells in the peripheral pulmonary compartments. A mast cell-dependent increase in IgE and IL-33 together with impairment of the IL-23/IL-17 axis was evoked in Wsh and Wsh+MC mice by allergen challenge. This study shows that within the same chronic murine asthma model the development of AHR can be both dependent and independent of mast cells. Moreover, the spatial distribution and number of pulmonary mast cells determine severity and localization of the AHR.
authors.affiliation: Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
authors.forename: Barbara
authors.initials: B
authors.lastname: Fuchs
authors.forename: Lisa
authors.initials: L
authors.lastname: Sjöberg
authors.forename: Christine
authors.initials: C
authors.lastname: Möller Westerberg
authors.forename: Maria
authors.initials: M
authors.lastname: Ekoff
authors.forename: Linda
authors.initials: L
authors.lastname: Swedin
authors.forename: Sven-Erik
authors.initials: SE
authors.lastname: Dahlén
authors.forename: Mikael
authors.initials: M
authors.lastname: Adner
authors.forename: Gunnar P
authors.initials: GP
authors.lastname: Nilsson
mesh_terms: D000485:Allergens / Q000009:adverse effects; D000818:Animals; D001249:Asthma / Q000473:pathology*; D016535:Bronchial Hyperreactivity / Q000473:pathology*; D002908:Chronic Disease; D004195:Disease Models, Animal; D005260:Female; D007073:Immunoglobulin E / Q000097:blood; D020381:Interleukin-17 / Q000032:analysis; D053759:Interleukin-23 / Q000032:analysis; D000067596:Interleukin-33; D007378:Interleukins / Q000032:analysis; D008168:Lung / Q000737:chemistry / Q000473:pathology*; D008407:Mast Cells / Q000473:pathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D010047:Ovalbumin / Q000276:immunology; D012720:Severity of Illness Index
chemical_list: D000485:Allergens; C506535:Il33 protein, mouse; D020381:Interleukin-17; D053759:Interleukin-23; D000067596:Interleukin-33; D007378:Interleukins; D007073:Immunoglobulin E; D010047:Ovalbumin